SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3058GILD as Munch-er: GILD CSO, Norbert W. Bischofberger, was at DNA during golden dMiljenko Zuanic-7/13/2016
3057EXEL??? Up almost 30% from its June Low; very heavy volume today!! i.e. on aIan@SI-7/1/2016
3056DEPO in hands of activists, RTRX, AMAG now holding too along with SUPN and AXGN.Robohogs-7/1/2016
3055INCY, RDUS, ONCE and ACAD (maybe OMED) holding well for now. Will see 2H-16 and Miljenko Zuanic-7/1/2016
3054PFE-AGN deal terms: siliconinvestor.comDewDiligence_on_SI-11/23/2015
3053TEVA acquires AGN's generic-drug business for $40.5B in cash and stock: silDewDiligence_on_SI-7/27/2015
3052Celgene to Acquire Receptos, Advancing Leadership in Immune-Inflammatory DiseaseThehammer-7/14/2015
3051AGN* acquires KYTH for $2.1B in cash+stock: siliconinvestor.com *Company was caDewDiligence_on_SI-6/17/2015
3050Speculation that Pfizer might take a crack at GSK... uk.finance.yahoo.com (GSK nigel bates-4/27/2015
3049A different view on ABBV-PCYC: twitter.comDewDiligence_on_SI-3/6/2015
3048PHARMALOT How Much Is One Cancer Drug Worth? By ED SILVERMAN March 6, 2015 WheDoc Bones-3/6/2015
3047FWIW - Jim Cramer obviously has a big audience - This was on Cramer's Thurs Doc Bones-3/6/2015
3046BTW, how much is today Opdivo worth? What part of BMY MC is Opdivo, and how muchMiljenko Zuanic-3/5/2015
3045Ridiculous price! Not even Avastin (at that time sole drug, no competition) wasMiljenko Zuanic-3/5/2015
3044It's a 39% premium relative to 2/24/15, when leaks surfaced re PCYC buyout bDewDiligence_on_SI13/5/2015
3043(Bloomberg) -- AbbVie Inc. beat out Johnson & Johnson with a last-minute bidDoc Bones-3/5/2015
3042We all heard about AbbVie buying Shire until the tax loophole closed before the tuck-3/5/2015
3041LONDON, Feb 24 (Reuters) - Dublin-based drugmaker Shire said on Tuesday it had bnigel bates-2/24/2015
3040London, UK, 4 December 2014: BTG Plc (BTG or the Company), the specialist healthnigel bates112/4/2014
3039SAN RAFAEL, Calif. (AP) -- BioMarin Pharmaceutical will pay $680 million in cashnigel bates-11/24/2014
3038Table of Recent Biotech Buyouts and Premiums (updated for Roche-ITMN): siliconinDewDiligence_on_SI-8/24/2014
3037Highest premium ever paid for a biotech buyout of its size, as far as I know: inDewDiligence_on_SI-6/9/2014
3036Some comments on the MRK-IDIX buyout: siliconinvestor.com siliconinvestor.com DewDiligence_on_SI-6/9/2014
3035MRK buys IDIX for almost $4B. marketwatch.com Idenix Pharmaceuticals Inc. IDIpgo-neil-6/9/2014
3034Slightly off the wall idea - would it be worth GSK's while to buy Incyte ?nigel bates-6/4/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News